% | $
Quotes you view appear here for quick access.

NuPathe AŞ Message Board

  • mj0077 mj0077 Nov 18, 2013 11:33 AM Flag

    This is not wishful thinking, but a deal of some sort has to be imminent.

    Few points to consider:
    AA stated considerable progress made in negotiations, with more than 1 suitor.
    Company has cash in hand to fund through Jan 2014. If PATH didn't believe a deal would take place, my thinking is they would have taken advantage of the stock runup 1-2 weeks ago to raise $$.
    The longer you have no deal, the stock will drip lower. Therefore, longer they wait, the equity financing is more dilutive. The indications point to a deal. On what terms, who knows. If no deal, BK for PATH.
    Would be hard to fathom with an FDA approved product, in a niche market. We shall see!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies